Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Atul Verma, MD
Southlake Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southlake Regional Health Centre
Newmarket, Ontario, Canada
- Montreal Heart Institute - Institut de Cardiologie de Montréal
Montreal, Quebec, Canada
- Quebec Heart and Lung Institute - Institut Universitaire de Cardiologie Et de Pneumologie de Québec
Québec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2016
- Primary completion
- 21 Apr 2021
- Completion
- 4 Oct 2021
- Last update posted
- 28 Apr 2022
- Registered enrollment
- 25
- Registry id
- NCT02994446
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.